Rankings
▼
Calendar
LFCR (Lifecore Biomedical, Inc.) Stock Financials & Earnings | Market Cap Arena
LFCR
Lifecore Biomedical, Inc.
Mkt Cap
$267M
Healthcare
·
Drug Manufacturers - Specialty & Generic
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$135M
Net Income (TTM)
-$32M
EPS (TTM)
-$1.07
Free Cash Flow (TTM)
-$10M
Gross Margin
31.6%
Op. Margin
-6.5%
Net Margin
-24.0%
FCF Margin
-7.1%
P/S Ratio (TTM)
2.0x
P/E Ratio (TTM)
—
YoY Rev Growth
+5.3%
Employees
—
Earnings Reports
▶
Q1 2026
Browse All Reports
Next: Q2 2026 · Mar 16
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q2 23
$22M
$6M
-$5M
Q3 23
$27M
$9M
-$7M
Q4 23
$26M
$8M
-$1M
Q1 24
$25M
$3M
-$9M
Q2 24
$30M
$10M
-$1M
Q3 24
$36M
$12M
-$895K
Q4 24
$38M
$17M
$2M
Q1 25
$25M
$5M
-$12M
Q2 25
$33M
$11M
-$2M
Q3 25
$35M
$10M
-$9M
Q4 25
$36M
$14M
$5M
Q1 26
$31M
$8M
-$3M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q2 23
2.0x
—
Q3 23
2.2x
—
Q4 23
2.7x
—
Q1 24
2.7x
—
Q2 24
2.5x
—
Q3 24
2.3x
—
Q4 24
2.1x
22.2x
Q1 25
2.1x
40.8x
Q2 25
2.0x
—
Q3 25
2.0x
—
Q4 25
2.1x
—
Q1 26
2.0x
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q2 23
-$2M
-$6M
Q3 23
-$15M
-$22M
Q4 23
-$272K
-$9M
Q1 24
-$8M
-$13M
Q2 24
$1M
-$3M
Q3 24
-$1M
-$8M
Q4 24
$9M
$6M
Q1 25
-$643K
-$4M
Q2 25
-$6M
-$9M
Q3 25
$1M
-$4M
Q4 25
$5M
$3M
Q1 26
$2M
$25K
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q2 23
$4M
Q3 23
$7M
Q4 23
$9M
Q1 24
$5M
Q2 24
$4M
Q3 24
$6M
Q4 24
$3M
Q1 25
$3M
Q2 25
$2M
Q3 25
$5M
Q4 25
$2M
Q1 26
$2M
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q2 23
-49.7%
-30.8%
Q3 23
-29.0%
-28.1%
Q4 23
-46.4%
-69.1%
Q1 24
+3.4%
+22.7%
Q2 24
+37.9%
+16.2%
Q3 24
+34.5%
+10.7%
Q4 24
+48.5%
+33.6%
Q1 25
+0.7%
+9.5%
Q2 25
+8.0%
+9.1%
Q3 25
-1.5%
+20.7%
Q4 25
-3.8%
-12.9%
Q1 26
+25.9%
-5.8%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q2 23
$0
0.0%
Q3 23
$0
0.0%
Q4 23
$816K
3.2%
Q1 24
$2M
6.3%
Q2 24
$2M
5.2%
Q3 24
$1M
4.2%
Q4 24
$2M
4.2%
Q1 25
$2M
9.8%
Q2 25
$3M
10.4%
Q3 25
$0
0.0%
Q4 25
$2M
5.0%
Q1 26
$2M
7.7%
marketcaparena.com
OpEx Breakdown
R&D
SG&A
Quarter
R&D
SG&A
Q2 23
$2M
$8M
Q3 23
$2M
$10M
Q4 23
$3M
$8M
Q1 24
$2M
$9M
Q2 24
$2M
$9M
Q3 24
$2M
$10M
Q4 24
$2M
$12M
Q1 25
$2M
$14M
Q2 25
$2M
$11M
Q3 25
$2M
$10M
Q4 25
$2M
$9M
Q1 26
$2M
$9M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q2 23
$7M
$0
$7M
Q3 23
$3M
$0
$3M
Q4 23
$19M
$0
$19M
Q1 24
$9M
$0
$9M
Q2 24
$3M
$0
$3M
Q3 24
$3M
$0
$3M
Q4 24
$8M
$0
$8M
Q1 25
$6M
$0
$6M
Q2 25
$9M
$0
$9M
Q3 25
$5M
$0
$5M
Q4 25
$8M
$0
$8M
Q1 26
$19M
$0
$19M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q2 23
30M
+2.4%
Q3 23
30M
+0.0%
Q4 23
30M
+0.1%
Q1 24
30M
+0.3%
Q2 24
36M
+19.8%
Q3 24
37M
+0.5%
Q4 24
31M
-16.5%
Q1 25
31M
+1.0%
Q2 25
34M
+11.4%
Q3 25
37M
+7.7%
Q4 25
37M
+0.0%
Q1 26
37M
+1.0%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 14
—
—
FY 15
—
—
FY 16
—
—
FY 17
—
—
FY 18
—
—
FY 19
—
—
FY 20
—
—
FY 21
—
—
FY 22
—
—
FY 23
$225K
459
FY 24
$245K
524
FY 25
$317K
406
marketcaparena.com